Z-FA-FMKZ-FA-FMK
MedChemExpress (MCE)
HY-P0109A
197855-65-5
(1S)-Z-FA-FMK
99.14%
-20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months
-20°C, 1 month (sealed storage, away from moisture)
Room temperature in continental US
may vary elsewhere.
Z-FA-FMK ((1S)-Z-FA-FMK) is a potent Cathepsin B and L inhibitor. Z-FA-FMK blocks the induction of DEVDase activity, DNA fragmentation, and externalization of phosphatidylserine by selective synthetic retinoid-related molecules (RRMs). Z-FA-FMK inhibits apoptosis. Z-FA-FMK inhibits caspase activity and selectively inhibits recombinant effector caspases 2, -3, -6, and -7. Z-FA-FMK is a viral inhibitor. Z-FA-FMK inhibits reovirus replication in a susceptible host.
Z-FA-FMK ((1S)-Z-FA-FMK
5-100 μM
1 h
Jurkat cells) reduces levels of DEVDase activity and DNA fragmentation. Z-FA-FMK inhibits the externalization of phosphatidylserine induced by either MX2870-1 or MX781[1]. Z-FA-FMK (100 μM
1 h
Jurkat cells) inhibits apoptosis. Z-FA-FMK inhibited the induction of DEVDase activity not only by the RRMs but also by other apoptotic insults, including etoposide-, ceramide-, and CD95/Fas receptor-mediated pathways[1]. Z-FA-FMK (0-100 μM
1 h
Jurkat cells) inhibits caspases 2, -3, -6, and -7 activity through repressed induction of DEVDase activity in Jurkat cells[1]. Z-FA-FMK (0-20 μM
48 h
HT1080 and mouse embryonic stem cells) blocks reoviral replication and cures cells of a persistent infection with reovirus in vitro[2]. Z-FA-FMK (20 μM
48 h
HT1080 cells) induces defects in reoviral maturation[2].
Z-FA-FMK (1 mg/kg
intratumor injection
every 2 d, for 27 d
SCID mice with HT1080 xenograft) blocks reovirus infection in vivo[2]. Z-FA-FMK (8 mg/kg
i.v.
every 2 d, once
male BALB/c mice) markedly lessens the degree of impairment seen in D-GalN/TNF-α-induced kidney injury[3].
Cathepsin B cathepsin L Caspase-2 Caspase-3 Caspase-6 Caspase-7
| | | |
| | | | | |
[1]. Lopez-Hernandez FJ, et, al. Z-FA-fmk inhibits effector caspases but not initiator caspases 8 and 10, and demonstrates that novel anticancer retinoid-related molecules induce apoptosis via the intrinsic pathway. Mol Cancer Ther. 2003 Mar
2(3):255-63. [Content Brief]
[2]. Kim M, et, al. Z-FA-FMK as a novel potent inhibitor of reovirus pathogenesis and oncolysis in vivo. Antivir Ther. 2010
15(6):897-905. [Content Brief]
[3]. Gezginci-Oktayoglu S, et, al. Effects of Z-FA.FMK on D-galactosamine/tumor necrosis factor-alpha-induced kidney injury and oxidative stress in mice : effects of Z-FA.FMK on TNF-alpha-mediated kidney injury. Mol Cell Biochem. 2008 Feb
309(1-2):9-20. [Content Brief]